Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
51P Taxane-based chemotherapy versus endocrine therapy pl... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
51P Taxane-based chemotherapy versus endocrine therapy plus CDK4/6 inhibitor as first-line treatment in hormone receptor-positive HER2-negative metastatic breast cancer that progressed on adjuvant endocrine therapy
0
Authors
Y.J. Yuan
7 more
Y.J. Yuan
•
Sen Wu
5 more
•
Zhongjing Jiang
Published
December 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Pulmonary And Respiratory Medicine
Metastatic Breast Cancer
Show all topics
DOI
10.1016/j.annonc.2024.10.072
